positions available now

Tag Archives: MOU

Budget 2013 – A changing PBS operating environment

For many Eye Spy readers, hearing no price related changes to the PBS was the best possible outcome of the 2013 Budget. A momentary sigh of relief, but upon closer inspection we see that the operating environment for medicines is changing in Australia despite repeated calls for certainly and predictability. Continue reading

Posted in Federal Budget, Life Sciences Industry, Market Access, PBS | Tagged , , , | Comments Off on Budget 2013 – A changing PBS operating environment

Election Watch 2013

In January, the Prime Minister stated she was “not starting the nation’s longest election campaign.” What she has started however, is a very long period of political lobbying from the pharmaceutical and healthcare industry. Continue reading

Posted in Life Sciences Industry, PBS | Tagged , | Comments Off on Election Watch 2013

Industry Insight – A Year Of Transparency And Contraction

Early in the year, the industry appeared to maintain the status quo as the MOU continued to provide a certain measure of predictability and certainty even as the PBS deferrals issue dragged on. The 2012 Federal Budget left the PBS … Continue reading

Posted in Life Sciences Industry, PBS, TGA | Tagged , , | Comments Off on Industry Insight – A Year Of Transparency And Contraction

Budget Bullet Dodged

We take a shot at assessing the recent Federal Budget’s impact on the Australian medicines industry. Continue reading

Posted in Federal Budget | Tagged | Comments Off on Budget Bullet Dodged

PBS Certainty. For Now.

We look at the Health Minister’s view of the Budget and question just how certain the PBS is. Continue reading

Posted in Federal Budget, Life Sciences Industry, PBS | Tagged , , | Comments Off on PBS Certainty. For Now.

PBS Flies Under the Radar

In the week leading up to Wayne Swan handing down his fourth Budget, tension built in the Health sector, especially amongst those in the medicines business. Now many are wondering what all the fuss was about. Continue reading

Posted in Federal Budget, Life Sciences Industry, PBS | Tagged , | Comments Off on PBS Flies Under the Radar

A Hypothetical Disclosure

We offer a hypothetical case to help you understand Extended and Accelerated Price Disclosure. Continue reading

Posted in Market Access, PBS | Tagged , | Comments Off on A Hypothetical Disclosure

The MoU Waiting Room

The industry is still waiting for the Government and Medicines Australia’s MoU to take effect. Continue reading

Posted in Life Sciences Industry | Tagged | Comments Off on The MoU Waiting Room

A Change in Understanding

Medicines Australia should be congratulated for negotiating a four-year Memorandum of Understanding on changes to the PBS. Continue reading

Posted in Federal Budget, Life Sciences Industry, PBS | Tagged , | Comments Off on A Change in Understanding

The Top 5: Opportunities from the Federal Budget

Here are five initiatives from the Budget we believe will offer commercial opportunities. Continue reading

Posted in E-Health/Technology, Federal Budget, Life Sciences Industry | Tagged , , | Comments Off on The Top 5: Opportunities from the Federal Budget
Copyright © 2014 Commercial Eyes